MHAT "Serdika" EOOD, Base 2 - Second Department of Medical Oncology

Sofia 1632

1 studies enrolling now · 1 studies all time

What they study most

Breast Cancer

Studies at this site

• Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2) — Recruiting now